JBT Marel Offers Unique Combination of Growth Drivers, Oppenheimer Says
JBT Marel (JBTM) is an interesting investment opportunity, given its unique combination of secular growth, high margin recurring revenue, and robust free cash flow generation, Oppenheimer said in a Thursday report.The company's protein segment is a leader in protein processing equipment, while its prepared foods business holds top market positions in downstream value-added preparation, preservation, and packaging of ready-to-eat foods, the Oppenheimer analysts said.JBT Marel appears positioned to outgrow the market by 200 to 300 basis points and deliver an organic revenue compound annual growth rate of 5% to 7% from fiscal 2025 through 2028, driven by revenue synergies and growth initiatives, according to the report.Oppenheimer initiated coverage of JBT Marel with an outperform rating and a $175 price target.Price: $128.78, Change: $+0.07, Percent Change: +0.05%